GlaxoSmithKline in Talks with Human Genome Sciences -Sources

by Charles Gross, Benzinga Editor
July 15, 2012 9:12 PM | 14 seconds read |
GlaxoSmithKline GSK is reportedly in discussions this weekend with Human Genome Sciences HGSI to increase its previous offer, according to Reuters. Human Genome had previously rejected GSK's $13/share bid. HGSI closed at $13.58 on Friday.
Market News and Data brought to you by Benzinga APIs

© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Comments
Posted In: NewsRumorsM&APre-Market Outlook
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!